Paper34945136
Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.
Rosi E and 5 others. J Clin Med, 2021. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic. Papers, record 34945136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34945136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References93
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34246359 | CoronaVac: more data for regulators and policy makers. | Lancet | 2021 | https://conductscience.org/library/papers/34246359 | PubMed |
| 2 | 34085330 | Anti-COVID-19 measurements for hidradenitis suppurativa patients. | Exp Dermatol | 2021 | https://conductscience.org/library/papers/34085330 | PubMed |
| 3 | 34453380 | COVID-19 and exacerbation of dermatological diseases: A review of the available literature. | Dermatol Ther | 2021 | https://conductscience.org/library/papers/34453380 | PubMed |
| 4 | 34282868 | May COVID-19 infection induce a paradoxical improvement of a non-responsive case of hidradenitis suppurativa? | Ital J Dermatol Venerol | 2021 | https://conductscience.org/library/papers/34282868 | PubMed |
| 5 | 34363647 | Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centre. | J Eur Acad Dermatol Venereol | 2021 | https://conductscience.org/library/papers/34363647 | PubMed |
| 6 | 33141505 | Emerging role of anti-IL23 in the treatment of psoriasis: When humanized is very promising. | Dermatol Ther | 2020 | https://conductscience.org/library/papers/33141505 | PubMed |
| 7 | 32432955 | Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment? | J Dermatolog Treat | 2022 | https://conductscience.org/library/papers/32432955 | PubMed |
| 8 | 32594549 | Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: a multicenter study in the Czech Republic. | J Eur Acad Dermatol Venereol | 2020 | https://conductscience.org/library/papers/32594549 | PubMed |
| 9 | 33977096 | NAFLD and Infection, a Nuanced Relationship. | Can J Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/33977096 | PubMed |
| 10 | 34350668 | Onset/flare of psoriasis following the ChAdOx1 nCoV-19 Corona virus vaccine (Oxford-AstraZeneca/Covishield): Report of two cases. | Dermatol Ther | 2021 | https://conductscience.org/library/papers/34350668 | PubMed |
| 11 | 33337329 | Hidradenitis suppurativa and adalimumab in the COVID-19 era. | Eur J Dermatol | 2020 | https://conductscience.org/library/papers/33337329 | PubMed |
| 12 | 33838206 | Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. | J Am Acad Dermatol | 2021 | https://conductscience.org/library/papers/33838206 | PubMed |
| 13 | 32338424 | Biologics for psoriasis in COVID-19 era: What do we know? | Dermatol Ther | 2020 | https://conductscience.org/library/papers/32338424 | PubMed |
| 14 | 33666256 | COVID-19 vaccination and patients with psoriasis under biologics: real-life evidence on safety and effectiveness from Italian vaccinated healthcare workers. | Clin Exp Dermatol | 2021 | https://conductscience.org/library/papers/33666256 | PubMed |
| 15 | 32406283 | A survey of psoriasis patients on biologics during COVID-19: a single centre experience. | J Dermatolog Treat | 2022 | https://conductscience.org/library/papers/32406283 | PubMed |
| 16 | 34170306 | Comparison of COVID-19 Vaccine Approvals at the US Food and Drug Administration, European Medicines Agency, and Health Canada. | JAMA Netw Open | 2021 | https://conductscience.org/library/papers/34170306 | PubMed |
| 17 | 33609286 | COVID-19 vaccination intention among patients with psoriasis compared with immunosuppressed patients with other skin diseases and factors influencing their decision. | Br J Dermatol | 2021 | https://conductscience.org/library/papers/33609286 | PubMed |
| 18 | 34145643 | Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study. | J Eur Acad Dermatol Venereol | 2021 | https://conductscience.org/library/papers/34145643 | PubMed |
| 19 | 32705945 | The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies. | J Dermatolog Treat | 2022 | https://conductscience.org/library/papers/32705945 | PubMed |
| 20 | 33948082 | Acrodermatitis Continua of Hallopeau Evolving into Generalized Pustular Psoriasis Following COVID-19: A Case Report of a Successful Treatment with Infliximab in Combination with Acitretin. | Biologics | 2021 | https://conductscience.org/library/papers/33948082 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CSF3 | 1440 | PubTator's text mining | https://conductscience.org/library/genes/1440 | NCBI Gene |
| CXCL10 | 3627 | PubTator's text mining | https://conductscience.org/library/genes/3627 | NCBI Gene |
| CXCL8 | 3576 | PubTator's text mining | https://conductscience.org/library/genes/3576 | NCBI Gene |
| IL12B | 3593 | PubTator's text mining | https://conductscience.org/library/genes/3593 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| IL23A | 51561 | PubTator's text mining | https://conductscience.org/library/genes/51561 | NCBI Gene |
| MAPK14 | 1432 | PubTator's text mining | https://conductscience.org/library/genes/1432 | NCBI Gene |
| TLR3 | 7098 | PubTator's text mining | https://conductscience.org/library/genes/7098 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34945136
GET https://conductscience.org/api/papers/v1/34945136/references?page=2